Acute splenic sequestration in HbSS: observations from the Jamaican birth cohort.

Child Health Epidemiology Genetics Global Health Paediatrics

Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
02 Nov 2023
Historique:
received: 03 08 2023
accepted: 10 10 2023
medline: 3 11 2023
pubmed: 3 11 2023
entrez: 2 11 2023
Statut: aheadofprint

Résumé

To document the prevalence, clinical features, haematology and outcome of acute splenic sequestration (ASS) in homozygous sickle cell disease (HbSS). A cohort study from birth. The Medical Research Council Laboratories at the University of the West Indies, Kingston, Jamaica. 311 cases of HbSS detected during the screening of 100 000 deliveries at the main government maternity hospital between 1973 and 1981. Long-term follow-up and free patient care focusing on ASS. Acute splenic sequestration. There were 183 episodes of ASS in 105 patients representing 35% of the cohort. The median age for first event was 1.07 years. During ASS, median values for haemoglobin fell by 32 g/dL, reticulocytes increased by 8% and total nucleated cells increased by 10.5%. ASS recurred in 47 (45%) patients. Conservative therapy in 133 episodes of 85 patients was associated with five deaths and splenectomy in 20 patients with 50 episodes had no deaths. Symptoms were generally non-specific but acute chest syndrome occurred in 17, and blood cultures revealed coagulase negative staphylococci in 5. The ASS case fatality rate was 3.6% and may be higher if autopsy evidence of ASS is included. There was no seasonal pattern but higher levels of fetal haemoglobin predicted patients less prone to ASS and its later occurrence. ASS remains an important cause of morbidity and mortality in HbSS in developing societies. ASS appears to be a non-specific response to many possible risk factors including coagulase negative staphylococci.

Identifiants

pubmed: 37918896
pii: archdischild-2023-326173
doi: 10.1136/archdischild-2023-326173
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Graham Serjeant (G)

Sickle Cell Trust (Jamaica), The Sickle Cell Trust, Kingston, Jamaica grserjeant@gmail.com.

Karlene Mason (K)

Faculty of Medical Sciences, University of the West Indies, Kingston, Jamaica.

Ian Hambleton (I)

Professor of Biostatistics, The University of the West Indies at Cave Hill, Bridgetown, Saint Michael, Barbados.

Beryl Serjeant (B)

Sickle Cell Trust (Jamaica), The Sickle Cell Trust, Kingston, Jamaica.

Classifications MeSH